biolife solutions - BLFS

BLFS

Close Chg Chg %
22.02 0.41 1.86%

Closed Market

22.43

+0.41 (1.86%)

Volume: 453.45K

Last Updated:

Feb 6, 2026, 4:00 PM EDT

Company Overview: biolife solutions - BLFS

BLFS Key Data

Open

$22.00

Day Range

21.35 - 22.66

52 Week Range

19.15 - 29.57

Market Cap

$1.09B

Shares Outstanding

48.15M

Public Float

46.44M

Beta

1.92

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.06

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

365.89K

 

BLFS Performance

No Data Available

BLFS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 10
Full Ratings ➔

Insider Actions for Biolife Solutions - BLFS

Date Name Shares Transaction Value
Nov 17, 2025 Roderick de Greef President and CEO; Director 421,163 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $25.88 per share 10,899,698.44
Nov 17, 2025 Roderick de Greef President and CEO; Director 389,998 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $25.33 per share 9,878,649.34
Nov 17, 2025 Roderick de Greef President and CEO; Director 454,581 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $26.15 per share 11,887,293.15
Jul 10, 2025 Troy Wichterman Chief Financial Officer 185,808 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.27 per share 4,137,944.16
Jul 10, 2025 Sarah Aebersold Chief Human Resources Officer 78,523 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.27 per share 1,748,707.21
Jul 10, 2025 Karen Foster Chief Quality and Operations 194,596 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.27 per share 4,333,652.92
Jul 10, 2025 Todd Berard Chief Marketing Officer 134,618 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.27 per share 2,997,942.86
Jul 10, 2025 Aby J. Mathew EVP & Chief Scientific Officer 352,582 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.27 per share 7,852,001.14
Mar 21, 2025 Sean Werner Chief Technology Officer 27,784 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Troy Wichterman Chief Financial Officer 214,929 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Rachel H. Ellingson Director 49,825 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Aby J. Mathew EVP & Chief Scientific Officer 320,165 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Tony J. Hunt Director 6,876 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Amy DuRoss Director 30,687 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Todd Berard Chief Marketing Officer 144,858 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Amy DuRoss Director 23,811 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $24.96 per share 594,322.56
Mar 21, 2025 Karen Foster Chief Quality and Operations 203,722 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Catherine Havlik Coste Director 5,701 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Joydeep Goswami Director 47,986 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 21, 2025 Sarah Aebersold Chief Human Resources Officer 85,865 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Biolife Solutions in the News